Bio-Link is a life sciences business development company which facilitates partnerships based on technology review, project management, business development and deal negotiation. Bio-Link has offices in Melbourne and Sydney.
Our clients include Australian biotech companies and medical research institutes as well as organisations located outside Australia. Our portfolio extends across small molecule and peptide drug candidates, genetic and protein biomarkers and other leading technologies.
Bio-Link adds value to the commercialisation process through critical assessment of patents, packaging of pre-clinical and clinical data, technology marketing and identification and engagement with potential collaborators, licensees, or investors.
Our team has experience in therapeutics and diagnostics and has been involved in a number of commercial transactions in the USA, Europe and Australia.
Please explore this website to gain more information about our team, our clients and our portfolio.
PYC Price at posting:
2.7¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)